Form 4: Director Sells SLAB Shares Under 10b5-1 Plan

Nina Richardson, a director at Silicon Laboratories Inc., sold 1,355 shares of common stock for $149 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Nina Richardson, a director of Silicon Laboratories Inc. (SLAB), reported a transaction involving the company's common stock.
• On January 13, 2026, Richardson disposed of 1,355 shares of common stock.
• The shares were sold at a price of $149 per share.
• This transaction was executed pursuant to a Rule 10b5-1 trading plan, which allows insiders to set up a pre-scheduled plan to sell shares.
• Following this transaction, Richardson beneficially owns 8,543 shares of Silicon Laboratories Inc. common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine insider sale under a pre-arranged 10b5-1 plan, which is generally considered neutral in terms of market sentiment as it is not indicative of new information or a reactive decision.

Positives

• The transaction was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled sale rather than a reactive decision, which can reduce concerns about opportunistic insider selling.

Negatives

• A director selling shares, even under a 10b5-1 plan, represents a decrease in insider ownership, which some investors may view as a minor negative signal.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction is a routine disclosure and does not provide specific insights into broader industry trends or competitive landscape for Silicon Laboratories Inc.

Stakeholder Impact

• Shareholders: A minor decrease in insider ownership, which is generally not considered significant given the pre-arranged nature of the sale and the relatively small number of shares.

Key Dates

Recommendation

The filing reports a routine insider sale by a director under a pre-arranged 10b5-1 trading plan. This type of transaction is generally not indicative of a change in the company's fundamental outlook and does not warrant a change in investment recommendation.

Keywords

Silicon Laboratories, SLAB, Insider Trading, Form 4, Stock Sale, Director Transaction, 10b5-1 Plan